PubMed:28623008 / 1528-1660 JSON TXT

Annnotations TAB JSON ListView MergeView

Id	Subject	Object	Predicate	Lexical cue
T18	36-39	CVCL_E806\|Transformed_cell_line\|Homo sapiens	denotes	PGF
T19	55-57	CVCL_Z998\|Spontaneously_immortalized_cell_line\|Drosophila melanogaster	denotes	P4
T20	98-100	CVCL_4U54\|Cancer_cell_line\|Rattus norvegicus	denotes	YS
T21	98-100	CVCL_7030\|Cancer_cell_line\|Homo sapiens	denotes	YS
T22	129-131	CVCL_4U54\|Cancer_cell_line\|Rattus norvegicus	denotes	YS
T23	129-131	CVCL_7030\|Cancer_cell_line\|Homo sapiens	denotes	YS

Id	Subject	Object	Predicate	Lexical cue
T251	22-28	UBERON:0001969	denotes	plasma
T252	36-39	PR:P49764	denotes	PGF
T254	36-39	PR:000012605	denotes	PGF
T256	36-39	PR:P49763	denotes	PGF
T258	36-39	PR:Q63434	denotes	PGF
T253	36-39	CVCL_E806	denotes	PGF
T255	36-39	CHEBI:26340	denotes	PGF
T257	36-39	D011460	denotes	PGF
T259	36-39	D011460	denotes	PGF
T260	48-54	UBERON:0001969	denotes	plasma

Id	Subject	Object	Predicate	Lexical cue
T9	0-132	Sentence	denotes	Moreover, it enhanced plasma OT and PGF levels; plasma P4 concentration was increased by low-dose YS, but decreased by high-dose YS.
T9	0-132	Sentence	denotes	Moreover, it enhanced plasma OT and PGF levels; plasma P4 concentration was increased by low-dose YS, but decreased by high-dose YS.